KKRAF yields 1.81% · JNJ yields 2.13%● Live data
📍 KKRAF pulled ahead of the other in Year 1
Combined, KKRAF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of KKRAF + JNJ for your $10,000?
Katakura Industries Co.,Ltd. engages in the textile, pharmaceutical, machinery, real estate, and life solutions businesses in Japan. The company manufactures and sells undergarments, hosiery products, aprons, and relaxing garments, as well as various functional fibers, such as the water-soluble fiber solvron and the thermal resistant NITIVY ALF. It also engages in the manufacture and sale of pharmaceuticals for treating cardiovascular illnesses comprising Frandol for the treatment of angina pectoris; and Frandol Tape, a heart medicine. In addition, the company manufactures and sells environment-related equipment (washers) and cutting oilrelated products, fire engines and firefighting-related equipment, and agricultural machinery, as well as car parts. Further, it provides commercial facility management services; and leases and develops various real estate lands. Additionally, the company offers agriculture-related products, food products, nursing care equipment, and general building maintenance and flower/tree planting services, as well as operates plant and pet specialty shops. The company was formerly known as Katakura Silk Spinning Co., Ltd. and changed its name to Katakura Industries Co.,Ltd. in November 1943. Katakura Industries Co.,Ltd. was founded in 1873 and is headquartered in Tokyo, Japan.
Full KKRAF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.